chr1-163069254-G-T

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_001102445.3(RGS4):​c.61G>T​(p.Ala21Ser) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000118 in 1,549,568 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/18 in silico tools predict a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000079 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00012 ( 2 hom. )

Consequence

RGS4
NM_001102445.3 missense, splice_region

Scores

1
14

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.339
Variant links:
Genes affected
RGS4 (HGNC:10000): (regulator of G protein signaling 4) Regulator of G protein signaling (RGS) family members are regulatory molecules that act as GTPase activating proteins (GAPs) for G alpha subunits of heterotrimeric G proteins. RGS proteins are able to deactivate G protein subunits of the Gi alpha, Go alpha and Gq alpha subtypes. They drive G proteins into their inactive GDP-bound forms. Regulator of G protein signaling 4 belongs to this family. All RGS proteins share a conserved 120-amino acid sequence termed the RGS domain. Regulator of G protein signaling 4 protein is 37% identical to RGS1 and 97% identical to rat Rgs4. This protein negatively regulate signaling upstream or at the level of the heterotrimeric G protein and is localized in the cytoplasm. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009649575).
BS2
High AC in GnomAd4 at 12 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
RGS4NM_001102445.3 linkuse as main transcriptc.61G>T p.Ala21Ser missense_variant, splice_region_variant 2/6 NP_001095915.1 P49798-3
RGS4NM_001113381.1 linkuse as main transcriptc.-231G>T 5_prime_UTR_variant 1/4 NP_001106852.1 P49798-4

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
RGS4ENST00000421743.6 linkuse as main transcriptc.61G>T p.Ala21Ser missense_variant, splice_region_variant 2/61 ENSP00000397181.2 P49798-3
RGS4ENST00000527393.5 linkuse as main transcriptn.83G>T splice_region_variant, non_coding_transcript_exon_variant 2/54

Frequencies

GnomAD3 genomes
AF:
0.0000789
AC:
12
AN:
152026
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00104
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000313
AC:
48
AN:
153360
Hom.:
0
AF XY:
0.000420
AC XY:
34
AN XY:
80910
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00173
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000118
Gnomad OTH exome
AF:
0.000467
GnomAD4 exome
AF:
0.000122
AC:
171
AN:
1397424
Hom.:
2
Cov.:
33
AF XY:
0.000163
AC XY:
112
AN XY:
689126
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.0000399
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00156
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000269
Gnomad4 OTH exome
AF:
0.000173
GnomAD4 genome
AF:
0.0000789
AC:
12
AN:
152144
Hom.:
0
Cov.:
32
AF XY:
0.000121
AC XY:
9
AN XY:
74368
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.000131
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00104
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000735
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000581
Hom.:
0
Bravo
AF:
0.0000604
ExAC
AF:
0.000258
AC:
13
Asia WGS
AF:
0.00115
AC:
4
AN:
3476

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsDec 03, 2021The c.61G>T (p.A21S) alteration is located in exon 2 (coding exon 2) of the RGS4 gene. This alteration results from a G to T substitution at nucleotide position 61, causing the alanine (A) at amino acid position 21 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.62
T
BayesDel_noAF
Benign
-0.68
CADD
Benign
12
DANN
Benign
0.93
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.16
N
LIST_S2
Benign
0.40
T
M_CAP
Benign
0.0099
T
MetaRNN
Benign
0.0096
T
MetaSVM
Benign
-1.0
T
PrimateAI
Benign
0.28
T
PROVEAN
Benign
-0.060
N
REVEL
Benign
0.064
Sift
Pathogenic
0.0
D
Vest4
0.13
MutPred
0.21
Gain of relative solvent accessibility (P = 0.0215);
MVP
0.27
MPC
0.37
ClinPred
0.027
T
GERP RS
-2.3
gMVP
0.070

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs568489938; hg19: chr1-163039044; API